AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8482443 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g/day mesalamine (in patients with ileum-only disease)
Number of subjects: 310
Study 8482443 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in patients with ileum-only disease)
Number of subjects: 310
Study 3156614 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg kg‐1 i.m.
Number of subjects: 0
Study 3156614 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 0.2 mg kg‐1 i.m.
Number of subjects: 0
Study 3156614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30852971 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus Clopidogrel (A+C) therapy (short-term, ≤1 month)
Number of subjects: 15434
Study 30852971 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus Clopidogrel (A+C) therapy (intermediate-term, ≤3 months)
Number of subjects: 15434
Study 30852971 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus Clopidogrel (A+C) therapy (long-term, >3 months)
Number of subjects: 15434
Study 30852971 — intervention group
Group type: COMPARATOR
Intervention: Aspirin monotherapy
Number of subjects: 15434
Study 29229354 — intervention group
Group type: EXPERIMENTAL
Intervention: Tac OD
Number of subjects: 45
Study 29229354 — intervention group
Group type: EXPERIMENTAL
Intervention: Tac BID
Number of subjects: 45
Study 29229354 — intervention group
Group type: COMPARATOR
Intervention: Tac OD and Tac BID
Number of subjects: 45
Study 27616162 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 8 weeks, 3 times a week, 8 whole-body exercises, 3 sets of 10-15 repetition maximum (RM)
Number of subjects: 38
Study 24533897 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex behavioural intervention (diet with lower glycemic index and physical activity)
Number of subjects: 1546
Study 24533897 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 1546
Study 22697367 — intervention group
Group type: EXPERIMENTAL
Intervention: Shaoyang specific acupuncture
Number of subjects: 480
Study 22697367 — intervention group
Group type: EXPERIMENTAL
Intervention: Shaoyang non-specific acupuncture
Number of subjects: 480
Study 22697367 — intervention group
Group type: EXPERIMENTAL
Intervention: Yangming specific acupuncture
Number of subjects: 480
Study 22697367 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 480
Study 19674876 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational antihypertensive drug
Number of subjects: 0
Study 19674876 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17525838 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery
Number of subjects: 0
Study 17525838 — intervention group
Group type: COMPARATOR
Intervention: Traditional surgical methods
Number of subjects: 0
Study 15585539 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief physiotherapy intervention (1-3 sessions using cognitive behaviour principles)
Number of subjects: 268
Study 15585539 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy
Number of subjects: 268
Study 11863327 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 1729
Study 10029616 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.0125, 0.025, or 0.1 mg orally)
Number of subjects: 32
Study 10029616 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (0.3 or 0.5 microgram.kg‐1.min‐1 intravenous)
Number of subjects: 32
Study 10029616 — intervention group
Group type: COMPARATOR
Intervention: Clonidine and placebo
Number of subjects: 32
Study 10029616 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined nitroglycerin plus clonidine
Number of subjects: 32
Study 10029616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 7779232 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized performance-based criteria for support surfaces
Number of subjects: 0
Study 2144266 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of large data bases in technology assessment
Number of subjects: 0
Study 2144266 — intervention group
Group type: EXPERIMENTAL
Intervention: Major approaches to technology assessment
Number of subjects: 0
Study 468444 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.8% THC inhalation
Number of subjects: 16
Study 468444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30377019 — intervention group
Group type: EXPERIMENTAL
Intervention: En bloc technique
Number of subjects: 53
Study 30377019 — intervention group
Group type: COMPARATOR
Intervention: Branched graft technique
Number of subjects: 53
Study 29850961 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 J/cm2
Number of subjects: 44
Study 29850961 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 J/cm2
Number of subjects: 44
Study 29850961 — intervention group
Group type: EXPERIMENTAL
Intervention: 105 J/cm2
Number of subjects: 44
Study 29850961 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study 24858914 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing personal protective equipment (PPE) during airway management
Number of subjects: 40
Study 24858914 — intervention group
Group type: COMPARATOR
Intervention: Not wearing personal protective equipment (PPE) during airway management
Number of subjects: 40
Study 25091346 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllogel Megafermenti(®) 2 bags/day for 8 weeks
Number of subjects: 29
Study 25091346 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin 2.8 g twice daily for 8 weeks
Number of subjects: 29
Study 23111651 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergocalciferol, 50,000 units, orally once a week for 8 weeks
Number of subjects: 12
Study 23111651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 23111651 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergocalciferol and Placebo
Number of subjects: 12
Study 19294365 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated humidifiers (HH)
Number of subjects: 30
Study 19294365 — intervention group
Group type: COMPARATOR
Intervention: Bubble humidifiers (BH)
Number of subjects: 30
Study 17446567 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental substance use disorders
Number of subjects: 0
Study 17446567 — intervention group
Group type: COMPARATOR
Intervention: CWS and substance abuse treatment systems
Number of subjects: 0
Study 15106850 — intervention group
Group type: EXPERIMENTAL
Intervention: EMF exposure before testing session
Number of subjects: 0
Study 15106850 — intervention group
Group type: COMPARATOR
Intervention: EMF exposure during data collecting session
Number of subjects: 0
Study 12044508 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine-radiotherapy (gemcitabine at 300 mg/m² concurrent with radiotherapy, three fractions of 8 Gy on days 1, 8, and 15; followed by gemcitabine alone at 1000 mg/m² weekly for 3 weeks every 4 weeks if compliance allowed)
Number of subjects: 24
Study 12044508 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-haematological toxicity
Number of subjects: 24
Study 12044508 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical resection post-chemoradiation
Number of subjects: 24
Study 9527088 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol, 1 g/kg body weight, mixed with 500 ml of juice
Number of subjects: 9
Study 9527088 — intervention group
Group type: COMPARATOR
Intervention: Alcohol, 1 g/kg body weight, mixed with 500 ml of juice plus 750 ml of mineral water
Number of subjects: 9
Study 7610803 — intervention group
Group type: COMPARATOR
Intervention: No otitis media episodes until 2 years of age (healthy children)
Number of subjects: 266
Study 7610803 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent acute otitis media (RAOM; > or = 4 episodes)
Number of subjects: 266
Study 7610803 — intervention group
Group type: EXPERIMENTAL
Intervention: Secretory otitis media (SOM)
Number of subjects: 266
Study 7610803 — intervention group
Group type: EXPERIMENTAL
Intervention: History of otitis media (RAOM or SOM)
Number of subjects: 266
Study 2231218 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 9
Study 881098 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow aspirin
Number of subjects: 18
Study 881098 — intervention group
Group type: COMPARATOR
Intervention: Plain aspirin
Number of subjects: 18
Study 31605461 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary angiotensinogen (uAOG)
Number of subjects: 0
Study 28093483 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir + lamivudine (300 mg atazanavir/100 mg ritonavir once daily and 300 mg lamivudine once daily)
Number of subjects: 266
Study 28093483 — intervention group
Group type: COMPARATOR
Intervention: Atazanavir/ritonavir + two NRTIs
Number of subjects: 266
Study 28093483 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir + lamivudine
Number of subjects: 266
Study 25814381 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication-assisted therapy (buprenorphine or methadone)
Number of subjects: 1039
Study 23870611 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarpogrelate CR 300 mg administered in the fasted condition
Number of subjects: 24
Study 23870611 — intervention group
Group type: COMPARATOR
Intervention: Sarpogrelate CR 300 mg administered after a high-fat breakfast
Number of subjects: 24
Study 22201239 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia SiHLE intervention
Number of subjects: 178
Study 22201239 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 178
Study 19258984 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided perivascular sural nerve block (group US) with 5 mL of 3% chloroprocaine
Number of subjects: 18
Study 19258984 — intervention group
Group type: COMPARATOR
Intervention: Traditional landmark-based sural nerve block (group TRAD) with 5 mL of 3% chloroprocaine
Number of subjects: 18
Study 19258984 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided perivascular sural nerve block (group US)
Number of subjects: 18
Study 19258984 — intervention group
Group type: COMPARATOR
Intervention: Traditional landmark-based sural nerve block (group TRAD)
Number of subjects: 18
Study 16960779 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-1 infected patients with CD4 <300 cells/microL
Number of subjects: 971
Study 16960779 — intervention group
Group type: COMPARATOR
Intervention: HIV-1 infection
Number of subjects: 971
Study 14722635 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective tidal volumes (6 ml/kg, respiratory rate: 15 breaths/min, PEEP 5 cmH(2)O, n=15)
Number of subjects: 44
Study 14722635 — intervention group
Group type: COMPARATOR
Intervention: Conventional tidal volumes with PEEP (10 ml/kg, respiratory rate: 9 breaths/min, PEEP 5 cmH(2)O, n=14)
Number of subjects: 44
Study 14722635 — intervention group
Group type: COMPARATOR
Intervention: Conventional tidal volumes without PEEP (10 ml/kg, respiratory rate: 9 breaths/min, n=15)
Number of subjects: 44
Study 14632857 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine
Number of subjects: 0
Study 10193959 — intervention group
Group type: EXPERIMENTAL
Intervention: 950 microsec pulsed CO2 laser with 3 passes at 300 mJ followed by Er:YAG laser with 2 passes at 1.7 J
Number of subjects: 10
Study 10193959 — intervention group
Group type: COMPARATOR
Intervention: 950 microsec pulsed CO2 laser with 2 passes at 300 mJ
Number of subjects: 10
Study 7579511 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive immunostaining for heat-shock protein-27 (HSP-27) using a polyclonal antibody (Hu27, dilution: 1/200)
Number of subjects: 890
Study 7579511 — intervention group
Group type: COMPARATOR
Intervention: Negative immunostaining for heat-shock protein-27 (HSP-27)
Number of subjects: 890
Study 2158487 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (intralesional stibogluconate injection and superficial cryotherapy)
Number of subjects: 15
Study 2158487 — intervention group
Group type: COMPARATOR
Intervention: Superficial cryotherapy
Number of subjects: 15
Study 2158487 — intervention group
Group type: COMPARATOR
Intervention: Intralesional stibogluconate injection alone
Number of subjects: 15
Study 6153721 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 582
Study 6153721 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin with probenecid
Number of subjects: 582
Study 6153721 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphonamide vaginal tablets
Number of subjects: 582
Study 6153721 — intervention group
Group type: COMPARATOR
Intervention: Direct microscopy
Number of subjects: 582
Study 31113481 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound dressings (NPD)
Number of subjects: 24
Study 31113481 — intervention group
Group type: COMPARATOR
Intervention: Static pressure dressings (SPD)
Number of subjects: 24
Study 28851451 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week exercise program with four 20-min exercise sessions on 3 days per week
Number of subjects: 85
Study 28851451 — intervention group
Group type: COMPARATOR
Intervention: Social stimulation program (Control Group)
Number of subjects: 85
Study 28851451 — intervention group
Group type: COMPARATOR
Intervention: Antipsychotic and sedative dosage quantified by olanzapine and diazepam equivalents
Number of subjects: 85
Study 25817183 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular 3g TXA plus 0.25mg DEP (1:200,000)
Number of subjects: 100
Study 25817183 — intervention group
Group type: COMPARATOR
Intervention: Topical 3g TXA alone
Number of subjects: 100
Study 23968817 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-knee arthroplasty
Number of subjects: 54
Study 23968817 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-knee arthroplasty
Number of subjects: 54
Study 23968817 — intervention group
Group type: COMPARATOR
Intervention: Healthy participants
Number of subjects: 54
Study 23968817 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-stand activity
Number of subjects: 54
Study 21047567 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers (BB)
Number of subjects: 3488
Study 19586227 — intervention group
Group type: EXPERIMENTAL
Intervention: CRA plus low monetary value vouchers (0.125 Euro, US$ 0.18)
Number of subjects: 96
Study 19586227 — intervention group
Group type: EXPERIMENTAL
Intervention: CRA plus high monetary value vouchers (0.25 Euro, US$ 0.36)
Number of subjects: 96
Study 19586227 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient treatment
Number of subjects: 96
Study 17149647 — intervention group
Group type: EXPERIMENTAL
Intervention: Brace free accelerated rehabilitation (group B)
Number of subjects: 45
Study 17149647 — intervention group
Group type: COMPARATOR
Intervention: Standard post-operative rehabilitation (group A)
Number of subjects: 45
Study 15055894 — intervention group
Group type: EXPERIMENTAL
Intervention: Eutectic mixture of local anaesthetic cream (EMLA) applied for 60 min followed by sham iontophoresis
Number of subjects: 28
Study 15055894 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine iontophoresis (2 mA for 10 min with lidocaine 4% and epinephrine 1 in 50,000)
Number of subjects: 28
Study 11176086 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microg sufentanil
Number of subjects: 80
Study 11176086 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg bupivacaine
Number of subjects: 80
Study 11176086 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 microg sufentanil plus 2.5 mg bupivacaine
Number of subjects: 80
Study 11176086 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 80
Study 9644411 — intervention group
Group type: EXPERIMENTAL
Intervention: Teen FreshStart with a buddy program (TFSB)
Number of subjects: 46
Study 9644411 — intervention group
Group type: EXPERIMENTAL
Intervention: Teen FreshStart program (TFS) without peer support
Number of subjects: 46
Study 9644411 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 46
Study 7935523 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent, progressive, isometric contractions of the ankle dorsiflexors
Number of subjects: 14
Study 31608653 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated irrigation pump (AIP)
Number of subjects: 80
Study 31608653 — intervention group
Group type: COMPARATOR
Intervention: Manual hand pump (HP)
Number of subjects: 80
Study 30335610 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral Spinal Bath (NSB)
Number of subjects: 30
Study 30335610 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral Spinal Spray (NSS)
Number of subjects: 30
Study 26868965 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct technique
Number of subjects: 0
Study 26868965 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect technique
Number of subjects: 0
Study 24979615 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Number of subjects: 8
Study 24979615 — intervention group
Group type: COMPARATOR
Intervention: Mixed diet
Number of subjects: 8
Study 22261004 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (2mg/kg plus 50 μg/kg/min)
Number of subjects: 24
Study 22261004 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 24
Study 22261004 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine without lidocaine (BC)
Number of subjects: 24
Study 22261004 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl without lidocaine (FC)
Number of subjects: 24
Study 22261004 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine and lidocaine (BL)
Number of subjects: 24
Study 22261004 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl and lidocaine (FL)
Number of subjects: 24
Study 20171455 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment (CGA) and subsequent intervention including medication adjustment, exercise instruction, nutrition support, physical rehabilitation, social worker consultation, and specialty referral.
Number of subjects: 310
Study 20171455 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 310
Study 18833146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryosupernatant plasma (CSNP)
Number of subjects: 60
Study 18833146 — intervention group
Group type: COMPARATOR
Intervention: Fresh frozen plasma
Number of subjects: 60
Study 16625443 — intervention group
Group type: EXPERIMENTAL
Intervention: Regensburg ambulation aid
Number of subjects: 10
Study 16625443 — intervention group
Group type: COMPARATOR
Intervention: Control group (ambulation training discontinued for at least 6 weeks)
Number of subjects: 10
Study 14503013 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0
Study 14503013 — intervention group
Group type: EXPERIMENTAL
Intervention: Other lipid lowering agents
Number of subjects: 0
Study 14503013 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-users of lipid-lowering agents)
Number of subjects: 0
Study 10789718 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 80 mg m(‐2) over 3 h and nolatrexed 500 mg m(‐2) day(‐1) as a 120‐h continuous intravenous infusion (Schedule 1)
Number of subjects: 9
Study 10789718 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 80 mg m(‐2) over 3 h and nolatrexed 500 mg m(‐2) day(‐1) as a 120‐h continuous intravenous infusion (Schedule 2)
Number of subjects: 9
Study 10789718 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 80 mg m(‐2) over 3 h and nolatrexed 500 mg m(‐2) day(‐1) as a 120‐h continuous intravenous infusion (Schedule 3)
Number of subjects: 9
Study 8969572 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil COER‐24 240 mg at 10 PM
Number of subjects: 95
Study 8969572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 1485477 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (400 mg for 7 days)
Number of subjects: 30
Study 1485477 — intervention group
Group type: COMPARATOR
Intervention: NaCl (control)
Number of subjects: 30
Study 3901374 — intervention group
Group type: EXPERIMENTAL
Intervention: GoLYTELY (polyethylene glycol-electrolyte lavage solution)
Number of subjects: 53
Study 3901374 — intervention group
Group type: COMPARATOR
Intervention: Traditional 3-day bowel preparation
Number of subjects: 53
Study 30558818 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent inactivated influenza vaccine (IIV4), two full doses 28 days apart.
Number of subjects: 5806
Study 30558818 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5806
Study 30558818 — intervention group
Group type: COMPARATOR
Intervention: Licensed trivalent split-virion inactivated vaccine (IIV3)
Number of subjects: 5806
Study 30558818 — intervention group
Group type: COMPARATOR
Intervention: Investigational IIV3 containing a B strain from the alternate lineage
Number of subjects: 5806
Study 29487335 — intervention group
Group type: EXPERIMENTAL
Intervention: Female subjects exhibiting exhibitionistic, frotteuristic, sexual sadistic, and pedophilic behavior
Number of subjects: 546
Study 29487335 — intervention group
Group type: EXPERIMENTAL
Intervention: Female subjects fulfilling diagnostic criteria for masochistic disorder
Number of subjects: 546
Study 29487335 — intervention group
Group type: COMPARATOR
Intervention: Control condition with psychotic symptoms
Number of subjects: 546
Study 26474116 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall risk assessment intervention
Number of subjects: 150
Study 26474116 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual group
Number of subjects: 150
Study 24949544 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D supplementation (9 doses of 50,000 IU of cholecalciferol over 24 weeks)
Number of subjects: 118
Study 24949544 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebo for vitamin D)
Number of subjects: 118
Study 24949544 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D supplementation
Number of subjects: 118
Study 24949544 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 21620465 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum chewing (GC) during class and testing
Number of subjects: 108
Study 21620465 — intervention group
Group type: COMPARATOR
Intervention: No gum chewing (NGC)
Number of subjects: 108
Study 19880855 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed LVEF (case group)
Number of subjects: 72
Study 19880855 — intervention group
Group type: COMPARATOR
Intervention: Normal LVEF (control group)
Number of subjects: 72